Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein - PubMed
The World Health Organization (WHO) estimates that seasonal influenza causes 3-5 million cases of severe illness annually. The influenza virus frequently undergoes genetic changes through antigenic drift and antigenic shift, resulting in annual epidemics and occasional pandemics. Consequently, a maj …
Urgent Vaccine Development Underway Against H5N1 Avian Flu
The threat of avian influenza remains front and center as the highly pathogenic strain, H5N1, spreads across North America and beyond, leading to urgent public…
Updated RNA vaccine protects mice against emerging H5N1 strain
A recent study published in Nature Communications by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators evaluated a replicating RNA (repRNA) vaccine designed to target a contemporary bovine-derived H5N1 virus and compared its efficacy to a vaccine based on a historical H5N1 strain used in stockpiled vaccines.
Groundbreaking Antibody Treatment Gives Hope Against H5N1 Flu
Researchers at the University of Pittsburgh and the NIH Vaccine Research Center have unveiled promising results from their study on a new antibody treatment aimed…